AstraZeneca also published efficacy data for Evusheld in patients with mild-to-moderate COVID-19, while Pfizer is investing $120m in expanding its Paxlovid manufacturing footprint in Michigan.
Moderna, Inc. plans to file for US Food and Drug Administration authorization of its bivalent, Omicron-specific COVID-19 vaccine candidate in the coming weeks and is hoping by late summer to be ready to start shipments in time for the fall.
The company announced positive data on 8 June from the Phase II/III study of mRNA-1273.214, showing superiority against the Omicron...
The first twice-yearly option for HIV prevention has been approved by the US Food and Drug Administration in an advance that “brings us closer than ever to ending the HIV epidemic,” said CEO Daniel O’Day.
Antibody-drug conjugates are a major part of the oncology pipeline, and data presented at the American Society of Clinical Oncology meeting highlight the emergence of new technologies.
Lilly’s Mounjaro for diabetes rose from sixth to third position among the top-selling drugs in the first quarter of 2025, Rival Ozempic retained second position and Merck & Co’s immuno-oncology blockbuster Keytruda stayed far ahead.
